Internal Medicine, Interventional Cardiology · Perry, GA
NPI
1831185388
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1117 Morningside Dr
Perry, GA, 31069
Phone (478) 224-1976
Groups this clinician bills Medicare through
Medicare paid, 2024
$604K
13,467 services
Medicare patients, 2024
992
Average age 74
Drug cost, 2024
$1.9M
12,106 prescriptions
Company payments, 2025
$923
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nasser S Tehrani was code 99457 (e&m - miscellaneous), 2,873 times for 407 patients. In total Nasser S Tehrani billed 13,467 services in 82 codes, and Medicare paid $604K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99457 E&M - Miscellaneous | Office | 2,873 | 407 | $34.09 | $98K |
| 99454 E&M - Miscellaneous | Office | 2,678 | 367 | $29.98 | $80K |
| 99458 E&M - Miscellaneous | Office | 1,856 | 364 | $27.53 | $51K |
| 93000 Electrocardiogram | Office | 734 | 502 | $9.51 | $6,980 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 687 | 108 | $46.82 | $32K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 644 | 160 | $4.72 | $3,041 |
| 99213 Office E&M - Established | Office | 582 | 398 | $59.35 | $35K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 474 | 92 | $35.63 | $17K |
| 99214 Office E&M - Established | Office | 400 | 277 | $86.77 | $35K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 338 | 173 | $86.01 | $29K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 301 | 145 | $46.13 | $14K |
| 93306 Echocardiography (TTE/TEE) | Office | 203 | 200 | $108.87 | $22K |
| 78452 Myocardial Perfusion Scan | Office | 181 | 180 | $286.60 | $52K |
| 93015 Electrocardiogram | Office | 174 | 173 | $45.36 | $7,892 |
| 99152 Anesthesia | Facility | 141 | 120 | $9.15 | $1,290 |
By year: 2022 $494K for 8,576 services; 2023 $558K for 11,518 services; 2024 $604K for 13,467 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nasser S Tehrani prescribed most often to Medicare patients was Ezetimibe, with 1,117 prescriptions and refills. In total Nasser S Tehrani wrote 12,106 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 1,117 | 2,837 | 451 | $16K |
| Clopidogrel Clopidogrel Bisulfate | 1,083 | 2,641 | 419 | $11K |
| Atorvastatin Calcium Generic | 1,050 | 2,549 | 391 | $9,290 |
| Ranolazine Er Ranolazine | 612 | 1,355 | 217 | $66K |
| Eliquis Apixaban | 596 | 1,057 | 171 | $597K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 498 | 1,198 | 196 | $5,162 |
| Carvedilol Generic | 467 | 1,098 | 175 | $3,362 |
| Furosemide Generic | 405 | 992 | 177 | $1,861 |
| Bisoprolol Fumarate Generic | 393 | 964 | 151 | $6,966 |
| Spironolactone Generic | 389 | 994 | 151 | $3,320 |
| Rosuvastatin Calcium Generic | 337 | 871 | 133 | $3,516 |
| Amlodipine Besylate Generic | 335 | 818 | 123 | $1,537 |
| Losartan Potassium Generic | 301 | 831 | 130 | $2,445 |
| Valsartan Generic | 300 | 678 | 96 | $7,684 |
| Entresto Sacubitril/Valsartan | 274 | 479 | 85 | $318K |
Brand drugs: 1,840 claims; generic drugs: 10,266 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nasser S Tehrani $923 ($923 in general payments such as food, travel and fees) from 13 companies. The largest payer was Shockwave Medical, Inc with $297.
| Company | Payments | Amount |
|---|---|---|
| Shockwave Medical, Inc JNJ | 2 | $297 |
| Boston Scientific Corporation BSX | 2 | $125 |
| Medtronic, Inc. MDT | 1 | $89.87 |
| Abiomed JNJ | 3 | $82.94 |
| Merck Sharp & Dohme LLC MRK | 4 | $82.79 |
| Philips North America LLC PHG | 2 | $49.35 |
| Pfizer Inc. PFE | 2 | $39.73 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $36.38 |
| Esperion Therapeutics, Inc. ESPR | 2 | $30.05 |
| Amgen Inc. AMGN | 2 | $29.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.